- Fee assured
- Verified this account
- Gynaecological oncology
- Sexual and reproductive healthcare
Mr. Jay Chatterjee is a Consultant Gynae-oncologist at the Royal Surrey County Hospital NHS Foundation Trust (Guildford) associated with the renowned St Luke's Cancer Centre. He is a sub-specialist in Gynaeoncology surgery, having done his fellowship at the prestigious West London Gynaeoncology Cancer center at the Hammersmith Hospital in London. He is also an honorary Clinical Senior Lecturer at Imperial College, London.
Mr Chatterjee provides all aspect of surgical gynaecological and gynaeoncological care, including colposcopy and coil insertion. He is internationally known for his surgical expertise in advanced open abdominal and laparoscopic operative skills. Mr Chatterjee did his doctoral studies looking at a novel immune pathway in ovarian cancer at Imperial College, London.
He has published widely in his chosen field of specialization.
Mr. Chatterjee has been extensively involved in postgraduate education in the UK and is the course director of the extremely popular MRCOG Part 1 revision course at Imperial College, London.
Mr Chatterjee was also a council member of the Royal College of Obstetricians and Gynaecologists and sat on numerous educational committees. He has written numerous chapters, books and questions and also been invited course tutor for MRCOG courses held in India and Dubai.
He has given numerous educational lectures nationally and internationally.
Areas of interest
Minimal Access Surgery in Gynaecology;
- Natalie Harris
- Nuffield Health Guildford Hospital Stirling Road Surrey Research Park Guildford GU2 7RF
- 01483 207286
- 07968 581975
- 01483 555978
Anaesthetists worked with
Current NHS consultant posts held
Mr. Jay Chatterjee is a Consultant Gynae-oncologist at the Royal Surrey County Hospital NHS Foundation Trust (Guildford) associated with the renowned St Luke's Cancer Centre.
Mr Chatterjee did his academic doctoral program at the prestigious Imperial College, London (Division of Surgery and Cancer, Institute of Reproductive and Developmental Biology, Hammersmith Hospital campus). His PhD focussed on an inhibitory T cell pathway, involved in dampening immune responses in ovarian Cancer. He has published extensively in his chosen field of specialization.
Mr Chatterjee’s research interest is in translational research, aimed at promoting new biomarker discovery and validation in gynaecological cancers. He has published on clinical interventions improving patient outcomes from gynaecological cancers. He is also part of the team involved in research in Human Uterine transplant in the UK. He is presently working to develop genomic, proteomic and immunomic characterisation of tumours, so that novel therapies can be applied as part of personalized cancer care to improve survival from gynaecological cancers.
Mr Chatterjee is a nature enthusiast and loves to go on long walks while on holidays. He keeps fit by playing various sports including Cricket, Tennis and swimming.
Outstanding Reviewer Award from the American Journal of Obstetrics and Gynecology (AJOG) -2011
Joint Runners-up prize for Best Poster Presentation at “Annual Blair–Bell Academic meeting” at RCOG, December’2012.
Awarded bursary from the BSCCP for attending and presenting at the IFCPC, London conference-2014
Awarded the best oral presentation Pan-London Colposcopy Scientific Meeting, 21st November 2014.
Rizzuto I, Stavraka C, Chatterjee J, Borley J, Glass-Hopkins T, Hani Gabra H, Ghaem-Maghami S, Huson L, Blagden S. Risk of ovarian cancer relapse (ROVAR) score: A prognostic algorithm to predict relapse following treatment for advanced ovarian cancer. Int. J. Gynecological Cancer. 2015 Mar; 25(3):416-22 (January 2015)
Chatterjee J, et al. Does Fertility Treatment Increase the Risk of Uterine Cancer? A Meta-Analysis. Eur J Obstet Gynecol Reprod Biol. 2015 Oct 3; 195:52-60.
Saso S, Petts G, Chatterjee J, Thum MY, David AL, Corless D, Boyd M, Noakes D, Lindsay I, Del Priore G, Ghaem-Maghami S, Smith JR. Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study. Eur J Obstet Gynecol Reprod Biol. 2014 Nov; 182: 185-93 (November 2014)
Christian J Maine, Nor Haslinda Abdul Aziz, Jayanta Chatterjee, Claudia Hayford, Nancy Brewig, Lynsey Whilding, Andrew JT George, Sadaf Ghaem Maghami Programmed death ligand-1 over expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunotherapy (December 2013)
Courses offered to GPs
“Gynaecological Cancers: Presentation, Investigation and evaluation from a physician’s perspective”- APICON, 28th-31st January 2016, Hyderabad, India. Invited Guest Lecturer and Chairperson for scientific sessions on Cancer and Immunotherapy
“Advances in surgical management of gynaecological cancers- have we made a difference?”- CME on “Advances in Gynaecology”- Dayanand Medical College, Ludhiana, India, 17th January 2015
- MRCOG Royal College of Obstetricians and Gynaecologists 2008
- PhD Imperial College, London 2015
Reference number 5204387
Details of entry to specialist register
- CCT in Obstetrics and Gynaecology and Gynae-oncology, 2015
Affiliations / memberships
British Society of Gynaecological Endoscopy
British Gynaecological Cancer Society
British Association of Cancer Research
European association of Cancer Research
British Society of Colposcopy and Cervical Pathology
Society for European Robotic Gynaecological Surgery
The Victor Bonney Society
The Blair Bell Research Society
British Medical Association
- 132 Harley Street, London
- 10:00 - 14:00
- 020 7563 1850
- Lister Hospital, Chelsea Bridge Road, London
- 10:00 - 14:00
- 020 3553 0972
- Nuffield Guildford Hospital, Stirling Road...
- 14:00 - 16:00
- 01483 207286
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details